The associations of sphingosine-1-phosphate with biomarkers of platelet activation, i.e., thromboxane B<sub>2</sub> and soluble P-selectin, as well as with clinical outcome in ischemic stroke or transient ischemic attack patients' subgroups with and without ASA has not yet been investigated. Here, SELP is linked to transient ischemic attack.